Join Dr. Adam Kinnaird for a look at the latest clinical research and the emerging applications that could shape the future of ExactVu™.
Micro-ultrasound is reshaping how urologists detect, target, and manage prostate cancer. As the clinical evidence grows, so does the range of questions it can help answer, from first-line diagnosis to active surveillance and beyond.
Whether you’re already using micro-ultrasound or evaluating it for your practice, this session will give you a clear picture of what the data shows today and where the technology is going.
In this webinar, you’ll learn:
Where micro-ultrasound fits in the current prostate cancer diagnostic pathway
Key insights from recent and ongoing clinical trials, including OPTIMUM
Emerging and future applications under investigation
The webinar will conclude with a live Q&A. Two sessions are offered to accommodate attendees across time zones; choose the one that works best for you.
Register
November 30, 2026
10 AM EST
Click or scan QR to register
November 30, 2026
3 PM EST
Click or scan QR to register
Presented By
Adam Kinnaird, MD, PhD, FRCSC University of Alberta
Adam Kinnaird, MD, PhD, FRCSC, is a urologic oncologist and researcher at the University of Alberta. He is the lead investigator of OPTIMUM, a multinational randomized controlled trial evaluating micro-ultrasound for prostate cancer diagnosis, and his research focuses on improving the accuracy and accessibility of prostate cancer imaging.